Peel Hunt Reaffirms “Add” Rating for Huntsworth (HNT)
A number of other brokerages also recently commented on HNT. Berenberg Bank decreased their target price on Huntsworth from GBX 150 ($1.96) to GBX 140 ($1.83) and set a buy rating for the company in a research note on Tuesday, November 27th. Numis Securities restated a buy rating on shares of Huntsworth in a research note on Friday, September 28th.
Shares of HNT stock opened at GBX 105 ($1.37) on Wednesday. Huntsworth has a 52 week low of GBX 40 ($0.52) and a 52 week high of GBX 95 ($1.24).
Huntsworth plc operates as a healthcare communications and public relations company in the United States, United Kingdom, rest of Europe, Asia, and the Middle East and Africa. It operates through four divisions: Huntsworth Health, Red Consultancy, Grayling, and Citigate Dewe Rogerson (CDR). The Huntsworth Health division offers an integrated suite of communications services for the science, health, and wellbeing industries.
Further Reading: Diversification For Individual Investors
Receive News & Ratings for Huntsworth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Huntsworth and related companies with MarketBeat.com's FREE daily email newsletter.